| scholarly article | Q13442814 |
| P2093 | author name string | Cordian Beyer | |
| Reza Mahmoudi | |||
| Parichehr Pasbakhsh | |||
| Iraj Ragerdi Kashani | |||
| Adib Zendedel | |||
| Ameneh Omidi | |||
| Hossein Chavoshi | |||
| Mahmoud Hassani | |||
| P2860 | cites work | Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis | Q27008133 |
| Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis | Q28080754 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. | Q33326648 | ||
| Iron and neurodegeneration in the multiple sclerosis brain | Q34470577 | ||
| Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage | Q36486079 | ||
| Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk | Q36653406 | ||
| Nutraceuticals against Neurodegeneration: A Mechanistic Insight | Q37168739 | ||
| Multiple sclerosis: experimental models and reality | Q37596784 | ||
| Multiple sclerosis and glutamate excitotoxicity. | Q38059846 | ||
| Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis. | Q38086168 | ||
| Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy | Q38086474 | ||
| Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis | Q38094613 | ||
| Pathology and disease mechanisms in different stages of multiple sclerosis | Q38111904 | ||
| The benefits and detriments of macrophages/microglia in models of multiple sclerosis | Q38120527 | ||
| Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives | Q38172120 | ||
| Glutathione in multiple sclerosis: more than just an antioxidant? | Q38212993 | ||
| Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection | Q38266313 | ||
| Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review | Q38743163 | ||
| Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor. | Q39131288 | ||
| Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice | Q39644014 | ||
| Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity | Q39660329 | ||
| 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice | Q40025304 | ||
| Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts | Q40572310 | ||
| Erythropoietin treatment enhances muscle mitochondrial capacity in humans. | Q42587694 | ||
| Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants | Q43846423 | ||
| Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination. | Q44448576 | ||
| Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis | Q45076147 | ||
| Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis | Q46290321 | ||
| Protective effect of erythropoietin on type II pneumocyte cells after traumatic brain injury in rats | Q46581416 | ||
| Effect of erythropoietin on brain tissue after experimental head trauma in rats | Q48129015 | ||
| Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination | Q48832325 | ||
| Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. | Q51017385 | ||
| On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans | Q59326138 | ||
| P433 | issue | 8 | |
| P921 | main subject | erythropoietin | Q218706 |
| cuprizone | Q27262585 | ||
| P304 | page(s) | 886-893 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Iranian Journal of Basic Medical Sciences | Q20850646 |
| P1476 | title | Protective effects of erythropoietin against cuprizone-induced oxidative stress and demyelination in the mouse corpus callosum | |
| P478 | volume | 20 |
Search more.